It is with giddy excitement, and genuine trepidation, that I write this brief end-of-the-year journal update, my first as the new editor in chief of JMT. My journey with JMT goes way back, first as a reader, then author (rejected and finally published), then reviewer, then editor of JMT’s “Art of Toxicology” feature where I wrote about semicolons and other strategies for writing precisely and without wordy run-ons (how ironic), then 3 years as associate editor, and now here I am. I look forward to this continuing journey. Readers should feel reassured that sudden big changes are not in store, but instead JMT’s trajectory will remain on the same course it had with Leslie Dye at the helm: upward.

Readers should also be reassured that JMT’s continued success will not depend on a single individual, but will always remain the product of the collective talents and experience of our enthusiastic authors, our dependable reviewers, our tireless editorial board, our diligent publishing staff at Springer, and the unconditionally supportive leadership of ACMT.

The recent change in editorial leadership comes with a few changes in responsibility on our board to support our upward momentum. Michelle Ruha is now the senior associate editor—in that role, she will oversee the features, be involved in content and policy issues, and help steer the journal into its second decade. Michelle has many years of experience at JMT where she has been a long-standing board member, served as case report editor, and most recently as review editor. Lewis Nelson, a name familiar to all in the world of toxicology, is now the editor of the Poison Pen section where letters to the editor are published. Managing the academic dialogue generated by letters from readers after a study is published requires experience and perspective, and Lewis certainly has the skills to lead that section well. Christine Murphy, formerly, a fellow-in-training member of our board and then promoted to full board membership, is now the associate editor of the fellow-in-training program at the journal. Developing young talent is an important priority for JMT, and Christine has the experience to ensure our fellow program remains a success.

We encourage readers to see our updated website. It includes links to articles available online first, helpful links for authors planning on submitting to the journal, a link to our informative and entertaining podcast from editors Howard Greller and Dan Rusyniak, and information for those interested in becoming a reviewer.

A few journal updates are important to note, many of which are not the result of a change in editorial leadership, but instead have been in the works for many months. First, JMT’s consent policy for case reports will be changing, so please see the editorial “Coming to a Consensus on Informed Consent for Case Reports” in this issue. Second, the annual Toxicology Investigators Consortium (ToxIC) report available in this issue will be regularly included every December—this year, it is even bigger and more comprehensive than last year’s, next year’s will undoubtedly be even bigger. Finally, please do not look for JMT in your mailbox in 2015—look for it online, as we are transitioning to be exclusively published in an electronic format with downloadable PDFs. The transition to an online-only journal also puts us in line with many other high-level journals and academic centers where print versions are no longer available in the library stacks. For those still interested in a print version, Springer will inform readers how to do so. This transition in 2015 ironically brings JMT’s history back full circle, as the precursor journal to JMT was the Internet Journal of Medical Toxicology (IJMT) launched in 1998. Thanks to the indefatigable efforts of Paul Wax and Mark Neavyn, archives of the old IJMT are also now available at our website.

Finally, it is important to express heartfelt thanks to Leslie Dye for her years of service as the editor in chief, and before that, as managing editor and associate editor. Leslie has been involved with every aspect of JMT since the very beginning—some of her remarkable accomplishments at JMT are mentioned in her “must-read” editorial also in this issue. Leslie always pushed our bar higher and higher, and her inexhaustible enthusiasm for JMT is one of the main reasons for this journal’s continued upward momentum today. We wish Leslie the very best in her ongoing journey in medical publishing.

For readers with any questions about our journal content or mission, please feel free to contact us directly via our website or at jmtinfo@acmt.net.